Transverse Myelitis After Therapy For Primitive Neuroectodermal Tumors

Pediatric Neurology

Volumn 35, Issue 2, 2006, Pages 122-125

  Ullrich, Nicole J ^a   Marcus, Karen ^a   Pomeroy, Scott L ^a   Turner, Christopher D ^a   Zimmerman, MaryAnn ^a   Lehmann, Leslie E ^a   Scott, R Michael ^a   Goumnerova, Liliana ^a   Gillan, Eileen ^b   Kieran, Mark W ^a   Chi, Susan N ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Division of Pediatric Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; STEROID; THIOTEPA; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN RADIATION; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG MEGADOSE; FEMALE; HUMAN; MALE; MYELITIS; NEUROECTODERM TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SPINAL CORD; STEM CELL TRANSPLANTATION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MYELITIS, TRANSVERSE; NEUROECTODERMAL TUMORS, PRIMITIVE; RADIOTHERAPY; STEM CELL TRANSPLANTATION;

EID: 33746192506     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2006.01.013     Document Type: Article

References (31)

1. Jakacki R.I. Pineal and nonpineal supratentorial primitive neuroectodermal tumors. Childs Nerv Syst 15 (1999) 586-591
2. Perez-Martinez A., Quintero V., Vicent M.G., Sevilla J., Diaz M.A., and Madero L. High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol 67 (2004) 101-106
3. Graham M.L., Herndon II J.E., Casey J.R., et al. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol 15 (1997) 1814-1823
4. Packer R.J., Gurney J.G., Punyko J.A., et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor. Childhood cancer survivor study. J Clin Oncol 21 (2003) 3255-3261
5. Marcus Jr. R.B., and Million R.R. The incidence of myelitis after irradiation of the cervical spinal cord. Int J Radiat Oncol Biol Phys 19 (1990) 3-8
6. Packer R.J., Meadows A.T., Rorke L.B., Goldwein J.L., and D'Angio G. Long-term sequelae of cancer treatment on the central nervous system in childhood. Med Pediatr Oncol 15 (1987) 241-253
7. Oberfield S.E., and Sklar C.A. Endocrine sequelae in survivors of childhood cancer. Adolesc Med 13 (2002) 161-169 viii
8. Johnson D.L., McCabe M.A., Nicholson H.S., et al. Quality of long-term survival in young children with medulloblastoma. J Neurosurg 80 (1994) 1004-1010
9. Fagioli F., Biasin E., Mastrodicasa L., et al. High-dose thiotepa and etoposide in children with poor-prognosis brain tumors. Cancer 100 (2004) 2215-2221
10. Mason W.P., Grovas A., Halpern S., et al. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol 16 (1998) 210-221
11. Gururangan S., McLaughlin C., Quinn J., et al. High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. J Clin Oncol 21 (2003) 2187-2191
12. Kalifa C., Valteau D., Pizer B., Vassal G., Grill J., and Hartmann O. High-dose chemotherapy in childhood brain tumours. Childs Nerv Syst 15 (1999) 498-505
13. Papadakis V., Dunkel I.J., Cramer L.D., et al. High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors. Bone Marrow Transplant 26 (2000) 153-160
14. Broniscer A., Nicolaides T.P., Dunkel I.J., et al. High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors. Pediatr Blood Cancer 42 (2004) 261-267
15. Foreman N.K., Schissel D., Le T., et al. A study of sequential high dose cyclophosphamide and high dose carboplatin with peripheral stem-cell rescue in resistant or recurrent pediatric brain tumors. J Neurooncol 71 (2005) 181-187
16. Kramer E.D., Packer R.J., Ginsberg J., et al. Acute neurologic dysfunction associated with high-dose chemotherapy and autologous bone marrow rescue for primary malignant brain tumors. Pediatr Neurosurg 27 (1997) 230-237
17. Sostak P., Padovan C.S., Yousry T.A., Ledderose G., Kolb H.J., and Straube A. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 60 (2003) 842-848
18. Ladriere M., Bibes B., Rabaud C., Delaby P., May T., and Canton P. [Varicella zoster virus infection after bone marrow transplant: Unusual presentation and importance of prevention]. Presse Med 30 (2001) 1151-1154
19. Ward K.N., White R.P., Mackinnon S., and Hanna M. Human herpesvirus-7 infection of the CNS with acute myelitis in an adult bone marrow recipient. Bone Marrow Transplant 30 (2002) 983-985
20. Gruhn B., Meerbach A., Egerer R., et al. Successful treatment of Epstein-Barr virus-induced transverse myelitis with ganciclovir and cytomegalovirus hyperimmune globulin following unrelated bone marrow transplantation. Bone Marrow Transplant 24 (1999) 1355-1358
21. Celik Y., Tabak F., Mert A., Celik A.D., and Aktuglu Y. Transverse myelitis caused by Varicella. Clin Neurol Neurosurg 103 (2001) 260-261
22. Richard S., Fruchtman S., Scigliano E., Skerrett D., Najfeld V., and Isola L. An immunological syndrome featuring transverse myelitis, Evans syndrome and pulmonary infiltrates after unrelated bone marrow transplant in a patient with severe aplastic anemia. Bone Marrow Transplant 26 (2000) 1225-1228
23. Jeremic B., Djuric L., and Mijatovic L. Incidence of radiation myelitis of the cervical spinal cord at doses of 5500 cGy or greater. Cancer 68 (1991) 2138-2141
24. Morris G.M., Coderre J.A., Hopewell J.W., et al. Response of the central nervous system to boron neutron capture irradiation. Evaluation using rat spinal cord model. Radiother Oncol 32 (1994) 249-255
25. Schultheiss T.E., Higgins E.M., and El-Mahdi A.M. The latent period in clinical radiation myelopathy. Int J Radiat Oncol Biol Phys 10 (1984) 1109-1115
26. Goldwein J.W. Radiation myelopathy. A review. Med Pediatr Oncol 15 (1987) 89-95
27. Schultheiss T.E. Spinal cord radiation tolerance. Int J Radiat Oncol Biol Phys 30 (1994) 735-736
28. Kim Y.H., and Fayos J.V. Radiation tolerance of the cervical spinal cord. Radiology 139 (1981) 473-478
29. Fowler J.F., Bentzen S.M., Bond S.J., et al. Clinical radiation doses for spinal cord. The 1998 international questionnaire. Radiother Oncol 55 (2000) 295-300
30. Dunst J., and Gebhart E. Unexpected tumor response, radiation myelitis and increased in vitro-radio-sensitivity of lymphocytes in a patient with non-small lung cancer. Radiother Oncol 36 (1995) 158
31. Schwartz D.L., Schechter G.P., Seltzer S., and Chauncey T.R. Radiation myelitis following allogeneic stem cell transplantation and consolidation radiotherapy for non-Hodgkin's lymphoma. Bone Marrow Transplant 26 (2000) 1355-1359